Alpha-Lipoic Acid Treatment Reduces Asymmetric Dimethylarginine in Patients with Type 2 Diabetes
In a study involving 30 patients with type 2 diabetes mellitus, intravenous administration of alpha-lipoic acid (ALA) for 3 weeks was found to reduce concentrations of asymmetric dimethylarginine (mean change:…